Valerio Therapeutics S.A.
ALVIO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€23,931 | -€20,344 | -€19,562 | -€5,937 |
| Dep. & Amort. | €11,314 | €507 | -€167 | €511 |
| Deferred Tax | €0 | €0 | €285 | €100 |
| Stock-Based Comp. | €390 | €514 | €724 | €224 |
| Change in WC | -€4,091 | -€665 | €6,875 | -€4,136 |
| Other Non-Cash | €3,858 | €1,391 | €2,402 | €666 |
| Operating Cash Flow | -€12,460 | -€18,597 | -€9,443 | -€8,572 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€319 | -€183 | -€488 | -€139 |
| Net Acquisitions | -€1,080 | €0 | €0 | €0 |
| Inv. Purchases | €0 | €0 | €0 | €0 |
| Inv. Sales/Matur. | €9 | €7 | €80 | €73 |
| Other Inv. Act. | €1 | -€1 | -€1 | €0 |
| Investing Cash Flow | -€1,389 | -€177 | -€409 | -€66 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€1,356 | -€1,223 | -€1,513 | €2,620 |
| Stock Issued | €24 | €12,114 | €7,974 | €9,352 |
| Stock Repurch. | €0 | -€125 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | €5,542 | -€7 | €2 | €4 |
| Financing Cash Flow | €4,210 | €10,759 | €6,463 | €11,976 |
| Forex Effect | €3,999 | €244 | €87 | €25 |
| Net Chg. in Cash | -€5,663 | -€7,771 | -€3,301 | €3,363 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €6,814 | €14,585 | €17,886 | €14,523 |
| End Cash | €1,151 | €6,814 | €14,585 | €17,886 |
| Free Cash Flow | -€12,779 | -€18,780 | -€9,931 | -€8,711 |